Just days after President Donald Trump signed an executive order fast-tracking the review of psychedelic drugs, more details emerged regarding the assets—and companies—that are set to benefit.
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the latest ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Food and Drug Administration (FDA) said Friday it will ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. A grower cuts psilocybin mushrooms to prepare for ...
Executive order to speed access to psychedelic treatments likely to have limited legal impact despite high-profile push The Trump administration issued an executive order earlier this month to ...
April 24 (Reuters) - The U.S. health regulator on Friday moved to speed up the development of new treatments for serious mental illness by awarding the national priority vouchers to three companies, ...
The FDA announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. It's a significant step toward supporting psychedelic-based medicines ...
The Food and Drug Administration on Friday granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. Subscribe to read this ...
The FDA is issuing national priority vouchers to three companies studying psychedelic drugs to treat serious mental illness. The agency also allowed an early phase clinical study of noribogaine ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Damian Garde is a ...
Some psychedelic drugs, once considered fringe, are getting a step closer to possibly being approved for use as mental health treatments in the United States. The US Food and Drug Administration on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results